Pfizer Inc plans to deliver more than 13 million doses per week of its Covid-19 vaccine to the United States by mid-March, more than double the volume sent in early February, a group executive said pharmaceutical in a deposition prepared in advance for its hearing Tuesday by the United States Congress.
Pfizer is on track to deliver 120 million doses of its vaccine in two injections by the end of March, said John Young, commercial director of Pfizer.
The lab is also set to deliver a total of 300 million doses to the United States by the end of July and expects to be able to increase its global production for 2021 to at least two billion doses, a- he added.
According to the deposition, also prepared in advance, from the president of Moderna Inc, Stephen Hoge, the American laboratory plans to deliver 100 million doses of its vaccine in two injections by the end of March, and 300 million by the end of March. at the end of July.
For its part, Johnson & Johnson believe they can ship at least 20 million doses of its single-dose vaccine to the United States by the end of March, after receiving the green light from the American health authority, and 100 million of doses by mid-2021, the group’s vice president of medical affairs, Richard Nettles, explained.
These depositions were prepared in anticipation of a congressional hearing on vaccine availability, to be hosted by the House of Representatives’ Energy and Trade Committee on Tuesday, as the United States crossed the bar on Monday. of the 500,000 deaths linked to COVID-19.
The announcements put the United States on track to receive 240 million doses by the end of March, enough to inoculate 130 million Americans, and 700 million doses by the start of the summer. (Carl O’Donnell, French version Laura Marchioro, edited by Blandine Hénault)